SEC Comment Letter for DBV Technologies S.A. (DBVT, DBVTF) (CIK 0001613780) (DBVT) — Sep 12, 2019
DBV Technologies S.A. (DBVT, DBVTF) (CIK 0001613780)
Date: Sept. 12, 2019 · CIK: 0001613780 · Accession: 0000000000-19-013492
AI Filing Summary & Sentiment
File numbers found in text: 333-233651
Letter
September 12, 2019 Daniel Tassé Chief Executive Officer DBV Technologies S.A. 177-181 Avenue Pierre Brossolette 92120 Montrouge France Re:DBV Technologies S.A. Registration Statement on Form F-3 Filed September 6, 2019 File No. 333-233651 Dear Mr. Tassé: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Christine Westbrook at 202-551-5019 with any questions. Sincerely, Division of Corporation Finance Office of Healthcare & Insurance cc: Richard Segal, Esq.
Show Raw Text
September 12, 2019
Daniel Tassé
Chief Executive Officer
DBV Technologies S.A.
177-181 Avenue Pierre Brossolette
92120 Montrouge France
Re:DBV Technologies S.A.
Registration Statement on Form F-3
Filed September 6, 2019
File No. 333-233651
Dear Mr. Tassé:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Christine Westbrook at 202-551-5019 with any questions.
Sincerely,
Division of Corporation Finance
Office of Healthcare & Insurance
cc: Richard Segal, Esq.